CA2770275C - An assay for determining a molecular risk assessment of a complex polymicrobial sample suspected to contain an ehec - Google Patents
An assay for determining a molecular risk assessment of a complex polymicrobial sample suspected to contain an ehec Download PDFInfo
- Publication number
- CA2770275C CA2770275C CA2770275A CA2770275A CA2770275C CA 2770275 C CA2770275 C CA 2770275C CA 2770275 A CA2770275 A CA 2770275A CA 2770275 A CA2770275 A CA 2770275A CA 2770275 C CA2770275 C CA 2770275C
- Authority
- CA
- Canada
- Prior art keywords
- seq
- fragment
- eae
- pair
- fifteen nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012502 risk assessment Methods 0.000 title claims abstract description 23
- 238000003556 assay Methods 0.000 title description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 150
- 101100516697 Citrobacter rodentium nleB gene Proteins 0.000 claims abstract description 132
- 101100240631 Escherichia coli O127:H6 (strain E2348/69 / EPEC) nleB1 gene Proteins 0.000 claims abstract description 132
- 101150118455 nleE gene Proteins 0.000 claims abstract description 120
- 238000000034 method Methods 0.000 claims abstract description 69
- 230000003321 amplification Effects 0.000 claims abstract description 62
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 62
- 241000588724 Escherichia coli Species 0.000 claims abstract description 60
- 230000008569 process Effects 0.000 claims abstract description 52
- 101100504328 Escherichia coli O157:H7 perA gene Proteins 0.000 claims abstract description 13
- 101150004681 rfbE gene Proteins 0.000 claims abstract description 13
- 239000012634 fragment Substances 0.000 claims description 148
- 239000002773 nucleotide Substances 0.000 claims description 148
- 125000003729 nucleotide group Chemical group 0.000 claims description 148
- 239000000523 sample Substances 0.000 claims description 116
- 230000008685 targeting Effects 0.000 claims description 93
- 101100516700 Escherichia coli O157:H7 nleF gene Proteins 0.000 claims description 66
- 238000001514 detection method Methods 0.000 claims description 37
- 101150082166 espK gene Proteins 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 26
- 241000588722 Escherichia Species 0.000 claims description 16
- 238000003753 real-time PCR Methods 0.000 claims description 11
- 230000005764 inhibitory process Effects 0.000 claims description 6
- 239000007850 fluorescent dye Substances 0.000 claims description 3
- -1 nleH1-2 Proteins 0.000 abstract description 3
- 239000013615 primer Substances 0.000 description 158
- 101150107911 eae gene Proteins 0.000 description 122
- 101100500479 Hafnia alvei eaeA gene Proteins 0.000 description 115
- 101100187060 Mus musculus Nid1 gene Proteins 0.000 description 101
- 108010079723 Shiga Toxin Proteins 0.000 description 40
- 108020004414 DNA Proteins 0.000 description 33
- 235000013305 food Nutrition 0.000 description 20
- 230000001018 virulence Effects 0.000 description 20
- 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 description 16
- 239000012636 effector Substances 0.000 description 14
- 101150117336 nleB2 gene Proteins 0.000 description 13
- 101710167241 Intimin Proteins 0.000 description 10
- 238000012512 characterization method Methods 0.000 description 10
- 230000002068 genetic effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 150000007523 nucleic acids Chemical group 0.000 description 9
- 230000007918 pathogenicity Effects 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 230000002550 fecal effect Effects 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 108700028369 Alleles Proteins 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 7
- 206010014896 Enterocolitis haemorrhagic Diseases 0.000 description 7
- 241000282412 Homo Species 0.000 description 7
- 101150000110 Nle gene Proteins 0.000 description 7
- 108010017898 Shiga Toxins Proteins 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 239000002987 primer (paints) Substances 0.000 description 7
- 241000588921 Enterobacteriaceae Species 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000000356 contaminant Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000369 enteropathogenic effect Effects 0.000 description 5
- 244000135860 Capparis spinosa subsp spinosa Species 0.000 description 4
- 230000004544 DNA amplification Effects 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 241000588923 Citrobacter Species 0.000 description 3
- 241000949031 Citrobacter rodentium Species 0.000 description 3
- 241000588731 Hafnia Species 0.000 description 3
- 102100039855 Histone H1.2 Human genes 0.000 description 3
- 101001035375 Homo sapiens Histone H1.2 Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 241000607768 Shigella Species 0.000 description 3
- 241000607734 Yersinia <bacteria> Species 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 238000003205 genotyping method Methods 0.000 description 3
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(IV) oxide Inorganic materials O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 3
- 208000031169 hemorrhagic disease Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 101150051941 nleB gene Proteins 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 101150003382 57 gene Proteins 0.000 description 2
- 101710112752 Cytotoxin Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 241000607760 Shigella sonnei Species 0.000 description 2
- 108010069584 Type III Secretion Systems Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 231100000599 cytotoxic agent Toxicity 0.000 description 2
- 239000002619 cytotoxin Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 210000001842 enterocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000304 virulence factor Substances 0.000 description 2
- 230000007923 virulence factor Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- COCMHKNAGZHBDZ-UHFFFAOYSA-N 4-carboxy-3-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(C([O-])=O)=CC=C1C(O)=O COCMHKNAGZHBDZ-UHFFFAOYSA-N 0.000 description 1
- HLXHCNWEVQNNKA-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1h-inden-2-amine Chemical compound COC1=CC=C2CC(N)CC2=C1 HLXHCNWEVQNNKA-UHFFFAOYSA-N 0.000 description 1
- WQZIDRAQTRIQDX-UHFFFAOYSA-N 6-carboxy-x-rhodamine Chemical compound OC(=O)C1=CC=C(C([O-])=O)C=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 WQZIDRAQTRIQDX-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 101150030286 71 gene Proteins 0.000 description 1
- 208000034309 Bacterial disease carrier Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 1
- 206010061126 Escherichia infection Diseases 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 238000007397 LAMP assay Methods 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 241000607149 Salmonella sp. Species 0.000 description 1
- 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
- 101100006379 Vibrio cholerae chxA gene Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000002416 diarrheagenic effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 101150072454 eac gene Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 244000000021 enteric pathogen Species 0.000 description 1
- 108010028810 enterohemolysin Proteins 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 208000020612 escherichia coli infection Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 244000078673 foodborn pathogen Species 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010235 multi-parametric assay Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 101150080727 stx gene Proteins 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09290621.3 | 2009-08-11 | ||
| EP09290621A EP2292799A1 (en) | 2009-08-11 | 2009-08-11 | An assay for determining a molecular risk assessment of stec isolates |
| PCT/IB2010/053631 WO2011018762A1 (en) | 2009-08-11 | 2010-08-11 | An assay for determining a molecular risk assessment of a complex polymicrobial sample suspected to contain an ehec |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2770275A1 CA2770275A1 (en) | 2011-02-17 |
| CA2770275C true CA2770275C (en) | 2020-03-31 |
Family
ID=41479602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2770275A Active CA2770275C (en) | 2009-08-11 | 2010-08-11 | An assay for determining a molecular risk assessment of a complex polymicrobial sample suspected to contain an ehec |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9416425B2 (es) |
| EP (2) | EP2292799A1 (es) |
| JP (1) | JP5990099B2 (es) |
| KR (1) | KR101837781B1 (es) |
| AU (1) | AU2010283452B2 (es) |
| BR (1) | BR112012003122B1 (es) |
| CA (1) | CA2770275C (es) |
| ES (1) | ES2614811T3 (es) |
| MX (1) | MX340945B (es) |
| NZ (1) | NZ598008A (es) |
| WO (1) | WO2011018762A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102260743B (zh) * | 2011-07-13 | 2013-03-06 | 浙江省疾病预防控制中心 | 肠出血性大肠杆菌o104:h4多重荧光pcr检测试剂盒 |
| JP5979657B2 (ja) * | 2011-08-16 | 2016-08-24 | 国立大学法人 東京大学 | 食中毒原因大腸菌検出用プライマー及び検出用キット |
| PL218839B1 (pl) | 2011-09-09 | 2015-01-30 | 3G Therapeutics Inc | Sposób wykrywania enterokrwotocznych Escherichia coli (EHEC), sonda do wykrywania enterokrwotocznych Escherichia coli (EHEC), sekwencje do amplifikacji fragmentu genu kodującego toksynę Shiga, zastosowanie sond i sekwencji |
| JP2014530011A (ja) | 2011-09-28 | 2014-11-17 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company | Stec細菌の配列ならびに検出および特徴決定のためのそれらの使用 |
| CA2862395A1 (en) * | 2011-12-30 | 2013-07-04 | Roka Bioscience, Inc. | Monitoring shiga toxin producing escherichia coli |
| EP2674501A1 (en) * | 2012-06-14 | 2013-12-18 | Agence nationale de sécurité sanitaire de l'alimentation,de l'environnement et du travail | Method for detecting and identifying enterohemorrhagic Escherichia coli |
| CA2916518A1 (en) * | 2013-07-03 | 2015-01-08 | Roka Bioscience, Inc. | Compositions, kits, and related methods for detecting and/or monitoring shiga toxin producing escherichia coli |
| EP2843057B1 (en) * | 2013-09-03 | 2017-12-27 | Pall Genedisc Technologies | Method for determining the presence or absence of shiga toxin-producing Escherichia coli (STEC) in a food sample |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2777907B1 (fr) | 1998-04-28 | 2002-08-30 | Pasteur Sanofi Diagnostics | Sequences nucleotidiques pour la detection des escherichia coli enterohemorragiques (ehec) |
| US6291168B1 (en) * | 1998-10-27 | 2001-09-18 | Auburn University | Nucleic acid sequences diagnostic for pathogenic E.coli O157:H7, methods of identification and kit therefore |
| US20060094034A1 (en) * | 2003-04-30 | 2006-05-04 | Roland Brousseau | Virulence and antibiotic resistance array and uses thereof |
| EP2383287A1 (en) * | 2003-10-31 | 2011-11-02 | The University of British Columbia | Citrobacter rodentium secreted proteins |
| US7323308B2 (en) * | 2004-09-03 | 2008-01-29 | Affymetrix, Inc. | Methods of genetic analysis of E. coli |
| CN100441696C (zh) | 2004-10-22 | 2008-12-10 | 中国疾病预防控制中心传染病预防控制所 | 肠出血性大肠杆菌o157:h7菌株的检测方法 |
-
2009
- 2009-08-11 EP EP09290621A patent/EP2292799A1/en not_active Withdrawn
-
2010
- 2010-08-11 ES ES10752414.2T patent/ES2614811T3/es active Active
- 2010-08-11 BR BR112012003122-8A patent/BR112012003122B1/pt not_active IP Right Cessation
- 2010-08-11 JP JP2012524325A patent/JP5990099B2/ja not_active Expired - Fee Related
- 2010-08-11 WO PCT/IB2010/053631 patent/WO2011018762A1/en not_active Ceased
- 2010-08-11 KR KR1020127006348A patent/KR101837781B1/ko not_active Expired - Fee Related
- 2010-08-11 AU AU2010283452A patent/AU2010283452B2/en not_active Ceased
- 2010-08-11 CA CA2770275A patent/CA2770275C/en active Active
- 2010-08-11 MX MX2012001854A patent/MX340945B/es active IP Right Grant
- 2010-08-11 US US13/389,957 patent/US9416425B2/en not_active Expired - Fee Related
- 2010-08-11 NZ NZ598008A patent/NZ598008A/en not_active IP Right Cessation
- 2010-08-11 EP EP10752414.2A patent/EP2464746B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX340945B (es) | 2016-08-01 |
| BR112012003122A2 (pt) | 2016-11-22 |
| JP5990099B2 (ja) | 2016-09-07 |
| KR101837781B1 (ko) | 2018-03-12 |
| CA2770275A1 (en) | 2011-02-17 |
| NZ598008A (en) | 2014-09-26 |
| EP2464746B1 (en) | 2016-11-30 |
| US9416425B2 (en) | 2016-08-16 |
| US20120202204A1 (en) | 2012-08-09 |
| AU2010283452A1 (en) | 2012-03-01 |
| BR112012003122B1 (pt) | 2019-10-29 |
| EP2292799A1 (en) | 2011-03-09 |
| KR20120100890A (ko) | 2012-09-12 |
| EP2464746A1 (en) | 2012-06-20 |
| JP2013501516A (ja) | 2013-01-17 |
| MX2012001854A (es) | 2012-05-22 |
| ES2614811T3 (es) | 2017-06-02 |
| AU2010283452B2 (en) | 2016-03-17 |
| WO2011018762A1 (en) | 2011-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102065053B1 (ko) | 장출혈성 대장균의 검출 및 식별 방법 | |
| CA2770275C (en) | An assay for determining a molecular risk assessment of a complex polymicrobial sample suspected to contain an ehec | |
| Nielsen et al. | Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5′ nuclease PCR assay | |
| Fukushima et al. | Duplex real-time SYBR green PCR assays for detection of 17 species of food-or waterborne pathogens in stools | |
| Bugarel et al. | Micro-array for the identification of Shiga toxin-producing Escherichia coli (STEC) seropathotypes associated with hemorrhagic colitis and hemolytic uremic syndrome in humans | |
| Bugarel et al. | Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates | |
| Higgins et al. | Genotyping of Escherichia coli from environmental and animal samples | |
| Li et al. | Real-time PCR methodology for selective detection of viable Escherichia coli O157: H7 cells by targeting Z3276 as a genetic marker | |
| Fan et al. | Rapid and sensitive Salmonella typhi detection in blood and fecal samples using reverse transcription loop-mediated isothermal amplification | |
| Schuurman et al. | Evaluation of 5′-nuclease and hybridization probe assays for the detection of shiga toxin-producing Escherichia coli in human stools | |
| US20100248238A1 (en) | Detection Of Bacteria Belonging to the Genus Campylobacter By Targeting Cytolethal Distending Toxin | |
| Pavlovic et al. | Development of a multiplex real-time polymerase chain reaction for simultaneous detection of enterohemorrhagic Escherichia coli and enteropathogenic Escherichia coli strains | |
| Hernández et al. | Quantitative detection of Clostridium perfringens by real-time pcr in raw milk | |
| Fukushima et al. | Comprehensive and Rapid Real‐Time PCR Analysis of 21 Foodborne Outbreaks | |
| JP2016000013A (ja) | 大腸菌の検出方法、及び大腸菌検出用担体 | |
| Ferdous | Shiga toxin-producing Escherichia coli (STEC) from Humans in the Netherlands: Novel diagnostic approach, molecular characterization and phylogenetic background | |
| Elvers et al. | Development of a strain-specific molecular method for quantitating individual Campylobacter strains in mixed populations | |
| Michel et al. | Genetic profiles of Shiga toxin and intimin genes found in stool broth cultures: a 2-year reference laboratory study | |
| Noll | Escherichia coli O157: detection and quantification in cattle feces by quantitative PCR, conventional PCR, and culture methods | |
| Wong | Insertion/deletion (Indel) Based Approach for the Detection of Escherichia coli O157: H7 in Freshwater Environments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20150721 |